Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Experimental Therapeutics

Efficacy of Liposomal Amphotericin B with Prolonged Circulation in Blood in Treatment of Severe Pulmonary Aspergillosis in Leukopenic Rats

Els W. M. Van Etten, Lorna E. T. Stearne-Cullen, Marian T. Ten Kate, Irma A. J. M. Bakker-Woudenberg
Els W. M. Van Etten
Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorna E. T. Stearne-Cullen
Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marian T. Ten Kate
Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irma A. J. M. Bakker-Woudenberg
Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.44.3.540-545.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Effects of a single dose (a) or double doses (b) of PEG-AMB-LIP versus multiple doses of AMB desoxycholate (c) on survival of persistently leukopenic rats with pulmonary aspergillosis (Kaplan-Meier plot). Leukopenic rats were inoculated in the left lobe of the lung with 2 × 104A. fumigatusconidia at time zero. Groups of 15 animals each were treated intravenously with PEG-AMB-LIP as a single dose of 10 mg of AMB/kg (■), a double dose (given every 72 h) of 10 mg of AMB/kg/dose (⧫) or a double dose (given every 72 h) of 14 mg of AMB/kg/dose (▴); AMB desoxycholate was administered for 10 consecutive days at 1 mg of AMB/kg/dose (●). Controls were treated with placebo liposomes (▵) or 5% glucose (○) or were left untreated (▿). Treatment was started 30 h after fungal inoculation, at which time mycelial growth was firmly established. ⧣, P ≤ 0.05; and ∗, P ≤ 0.005, versus untreated or placebo-treated rats.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Effects of a single dose (a) or double doses (b) PEG-AMB-LIP versus multiple doses of AMB desoxycholate (c) on survival of temporarily leukopenic rats with pulmonary aspergillosis (Kaplan-Meier plot). For explanation of symbols and panels, see the legend to Fig. 1.

Tables

  • Figures
  • Table 1.

    Effects of a single dose or double doses of PEG-AMB-LIP versus multiple doses of AMB desoxycholate on presence of viableA. fumigatus in the left lung and dissemination to the right lung and liver at the time of death in persistently or temporarily leukopenic ratsa

    TreatmentbDaily dose of AMB (mg/kg)No. of doses (dosing interval [h])No. of culture-positive organsc/total no. of ratsd
    Left lungRight lungLiver
    PTPTPT
    Untreated15/1515/1514/1512/1510/159/15
    PEG-AMB-LIP101 15/1515/1513/1512/151/15e2/15f
    PEG-AMB-LIP102 (72)15/1515/159/158/150/15e0/15e
    PEG-AMB-LIP142 (72)15/1515/159/158/150/15e0/15e
    AMB desoxycholate110 (24)15/1515/159/15f6/15e1/15e1/15e
    Placebo liposomes2 (72)15/1515/1512/1512/1511/158/15
    Placebo (glucose)10 (24)15/1515/1515/1514/1510/158/15
    • ↵a Leukopenic rats were inoculated in the left lung at time zero with 2 × 104A. fumigatus conidia.

    • ↵b PEG-AMB-LIP, AMB desoxycholate, or placebo treatment was administered intravenously.

    • ↵c Effect of treatment was determined by postmortem cultures.

    • ↵d P, persistent leukopenia; T, temporary leukopenia.

    • ↵e P ≤ 0.005 versus placebo treatment.

    • ↵f P ≤ 0.05 versus placebo treatment.

PreviousNext
Back to top
Download PDF
Citation Tools
Efficacy of Liposomal Amphotericin B with Prolonged Circulation in Blood in Treatment of Severe Pulmonary Aspergillosis in Leukopenic Rats
Els W. M. Van Etten, Lorna E. T. Stearne-Cullen, Marian T. Ten Kate, Irma A. J. M. Bakker-Woudenberg
Antimicrobial Agents and Chemotherapy Mar 2000, 44 (3) 540-545; DOI: 10.1128/AAC.44.3.540-545.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of Liposomal Amphotericin B with Prolonged Circulation in Blood in Treatment of Severe Pulmonary Aspergillosis in Leukopenic Rats
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy of Liposomal Amphotericin B with Prolonged Circulation in Blood in Treatment of Severe Pulmonary Aspergillosis in Leukopenic Rats
Els W. M. Van Etten, Lorna E. T. Stearne-Cullen, Marian T. Ten Kate, Irma A. J. M. Bakker-Woudenberg
Antimicrobial Agents and Chemotherapy Mar 2000, 44 (3) 540-545; DOI: 10.1128/AAC.44.3.540-545.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

amphotericin B
antifungal agents
aspergillosis
Aspergillus fumigatus
Leukopenia
Lung Diseases, Fungal

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596